Clinical Trial Update: Safety and Efficacy of Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops Treatment for Dry Eye Diseases Post Refractive Surgery and Associated With Blepharospasm [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety and efficacy of PSC-MSC-Exo eye drops for dry eye disease after refractive surgery and blepharospasm, status currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• PSC-MSC-Exo eye drops (pluripotent stem cell-derived mesenchymal stem cell exosome)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: UNKNOWN